These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31369867)

  • 21. Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort.
    Rubio Vargas R; van den Berg R; van Lunteren M; Ez-Zaitouni Z; Bakker PA; Dagfinrud H; Ramonda R; Landewé R; Molenaar E; van Gaalen FA; van der Heijde D
    RMD Open; 2016; 2(1):e000283. PubMed ID: 27403336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis.
    Schneeberger EE; Zamora N; Citera G
    Clin Rheumatol; 2016 Nov; 35(11):2865-2866. PubMed ID: 27357718
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.
    Godfrin-Valnet M; Prati C; Puyraveau M; Toussirot E; Letho-Gyselink H; Wendling D
    Joint Bone Spine; 2013 Jul; 80(4):393-8. PubMed ID: 23453478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up.
    Berg IJ; Semb AG; van der Heijde D; Kvien TK; Olsen IC; Dagfinrud H; Provan SA
    Ann Rheum Dis; 2015 Aug; 74(8):1562-6. PubMed ID: 25795906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.
    van der Heijde D; Molto A; Ramiro S; Braun J; Dougados M; van Gaalen FA; Gensler LS; Inman RD; Landewé RBM; Marzo-Ortega H; Navarro-Compán V; Phoka A; Poddubnyy D; Protopopov M; Reveille J; Rudwaleit M; Sampaio-Barros P; Sepriano A; Sieper J; Van den Bosch FE; van der Horst-Bruinsma I; Machado PM; Baraliakos X
    Ann Rheum Dis; 2024 Apr; 83(5):547-549. PubMed ID: 38071514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of sacroiliac joint MRI and added value of spine MRI to detect active spondyloarthritis.
    Plier M; Nzeusseu Toukap A; Michoux N; Stoenoiu MS; Kirchgesner T; Durez P; Lauwerys B; Lecouvet FE
    Diagn Interv Imaging; 2021 Mar; 102(3):171-180. PubMed ID: 32830083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity.
    Wiąk-Walerowicz K; Wielosz E
    Reumatologia; 2024; 62(1):64-69. PubMed ID: 38558891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between clinical and MRI disease activity scores in axial spondyloarthritis.
    MacKay JW; Aboelmagd S; Gaffney JK
    Clin Rheumatol; 2015 Sep; 34(9):1633-8. PubMed ID: 25894437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
    Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
    Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.
    Poddubnyy D; Protopopov M; Haibel H; Braun J; Rudwaleit M; Sieper J
    Ann Rheum Dis; 2016 Dec; 75(12):2114-2118. PubMed ID: 27125522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
    Bodur H; Yurdakul FG; Ataman S; Cay HF; Gurer G; Capkin E; Sezer İ; Duruoz MT; Melikoglu MA; Rezvani A; Yagci I; Gogus F; Kamanli A; Akgul O; Cevik R
    Clin Rheumatol; 2022 Jul; 41(7):2053-2063. PubMed ID: 35353263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis.
    Chung HY; Chui ETF; Lee KH; Tsang HHL; Chan SCW; Lau CS
    RMD Open; 2019; 5(2):e001008. PubMed ID: 31452930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C-Reactive Protein Levels.
    Tam HKJ; Nash P; Robinson PC
    ACR Open Rheumatol; 2021 Oct; 3(10):699-706. PubMed ID: 34405589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study.
    Nam B; Koo BS; Lee TH; Shin JH; Kim JJ; Lee S; Joo KB; Kim TH
    BMC Musculoskelet Disord; 2021 Feb; 22(1):140. PubMed ID: 33541326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?
    Au YL; Wong WS; Mok MY; Chung HY; Chan E; Lau CS
    Clin Rheumatol; 2014 Aug; 33(8):1127-34. PubMed ID: 24981160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula.
    Aranda-Valera IC; Garrido-Castro JL; Ladehesa-Pineda L; Vazquez-Mellado J; Zarco P; Juanola X; Gonzalez-Navas C; Font-Ugalde P; Castro-Villegas MC
    Rheumatology (Oxford); 2020 Jul; 59(7):1545-1549. PubMed ID: 31628804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS.
    Molto A; Gossec L; Meghnathi B; Landewé RBM; van der Heijde D; Atagunduz P; Elzorkany BK; Akkoc N; Kiltz U; Gu J; Wei JCC; Dougados M;
    Ann Rheum Dis; 2018 Jan; 77(1):124-127. PubMed ID: 29038299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.
    Ørnbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindström U; Askling J; Michelsen B; Giuseppe DD; Wallman JK; Pavelka K; Závada J; Nissen MJ; Jones GT; Relas H; Pirilä L; Tomšič M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; van Sder Horst-Bruinsma I; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Østergaard M; Hetland ML
    Semin Arthritis Rheum; 2022 Oct; 56():152081. PubMed ID: 35985172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.